Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
09/2003
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003040256A3 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
09/18/2003WO2003037308A3 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176454 N-coating heterocyclic compounds
09/18/2003US20030176432 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids
09/18/2003US20030176415 1,2,3,4-tetrahydroisoquinoline derivatives
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/17/2003EP1343796A2 Compounds and methods
09/17/2003EP1343753A2 Antimicrobial agents
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003CN1443170A Capsaicin receptor ligands
09/16/2003US6620938 Compounds that inhibit GRB2-SHC binding and process for preparing same
09/16/2003US6620827 PPARγ modulators
09/16/2003CA2085802C 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl) -2,3-pyridinedicarboxylic acids
09/12/2003WO2003074512A1 Isoquinoline derivatives
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2002022550A3 Chiral amino alcohols and process for preparation of same
09/12/2003WO2002004443A3 Heterocycle carboxamides as antiviral agents
09/12/2003CA2478618A1 Isoquinoline derivatives
09/11/2003US20030171580 Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
09/11/2003US20030171461 Process for the synthesis of amine ethers from secondary amino oxides
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341765A1 Therapeutic compounds
09/10/2003EP1037633B1 Antiviral compounds
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441784A Thrombin inhibitors comprising aminoisoquinoline group
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/09/2003US6617457 Hydrogenolysis of the benzyl ester of quinapril in an alcoholic solvent, with hydrochloric acid and hydrogenation; removal of the solvent; addition of toluene to precipitate the product as a solvate
09/09/2003US6617454 Process for the preparation of amine oxides
09/09/2003CA2183155C Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria
09/04/2003WO2003072558A2 Arylsulfone derivatives
09/04/2003WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003US20030166929 Heterocyclic compounds useful as inhibitors of tyrosine kinases
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166579 Thrombin inhibitors comprising an aminoisoquinoline group
09/04/2003CA2476173A1 Arylsulfone derivatives
09/04/2003CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339692A1 Novel compounds for use as hiv protease inhibitors
09/03/2003EP1339686A2 Cyanoguanidine prodrugs
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1194403B1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
09/03/2003EP0775689B1 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/03/2003CN1440390A Substituted diamide derivatives useful as motilin antagonists
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/02/2003US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/2003
08/28/2003WO2003070709A1 Novel phenylalanine derivative
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070247A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162799 Squaric acid derivatives
08/28/2003US20030162690 Bood anticoagulant
08/28/2003CA2476936A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337515A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
08/27/2003EP1337514A1 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
08/26/2003US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis.
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders
08/21/2003WO2003068750A1 Jnk inhibitor
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
08/21/2003WO2003068229A1 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030158198 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/21/2003US20030158188 An antagonists for treating pain, inflammations, urinary incontinence and bladder overactivity
08/21/2003CA2476162A1 Jnk inhibitor
08/21/2003CA2475783A1 Benzenesulfonamide derivatives as antipsychotic agents
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003CN1118464C Novel pyrimidine derivatives and process producing the same
08/19/2003US6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
08/19/2003US6608196 Structurally diverse; parallel approach
08/19/2003US6608193 Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
08/19/2003US6608082 Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands
08/14/2003WO2003066597A2 Guanidino compounds
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153510 Novel compounds inhibiting factor xa activity
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP0885888B1 Isoquinoline derivatives and drugs
08/12/2003US6605721 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
08/07/2003WO2003064389A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 119